The role of chemokines in proangiogenic action induced by human adipose tissue-derived mesenchymal stem cells in the murine model of hindlimb ischemia

Cellular Physiology and Biochemistry

Volumn 24, Issue 5-6, 2009, Pages 511-518

  Cho, Hyun Hwa ^a,b   Kim, Yeon Jeong ^a,b   Kim, Jong Tae ^a   Song, Ji Sun ^a,b   Shin, Keun Koo ^a,b   Bae, Yong Chan ^a   Jung, Jin Sup ^a,b,c  

^a Pusan National University School of Medicine   (South Korea)

^b Institute of Cardiovascular Research   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

Capillary like structure formation; GCP2; HASCs; MCP1; Proangiogenic action

Indexed keywords

GRANULOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADIPOSE TISSUE; ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HINDLIMB; HUMAN; HUMAN CELL; LEG ISCHEMIA; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

MURINAE;

EID: 70450257791     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000257495     Document Type: Article

References (44)

1. Folkman J, Cotran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976;16:207-248.
2. Auerbach R: Angiogenesis-inducing factors: a review, Lymphokines. Edited by E Pick. New York, Academic Press 1981;4:69-88.
3. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
4. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987;235:442-447.
5. Leibovich SJ, Wiseman DM: Macrophages, wound repair and angioge-nesis. Prog Clin Biol Res 1988;266:131-145.
6. Carlson BM, Faulkner JA: The regeneration of skeletal muscle fibers following injury. Med Sci Sports Exerc 1983;15:187-198.
7. Luster AD: Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
8. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S: CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 2004;25:201-209.
9. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-228.
10. Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM, Rice HE: Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002;294:371-379.
11. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005:332:370-379.
12. Kim YJ, Bae YC, Suh KT, Jung JS: Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 2006;72:1268-1278.
13. Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, Werner C: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004;22:377-384. (Pubitemid 38736621)
14. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K: Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 2003;75:204-209.
15. Kim Y, Kim H, Cho H, Bae Y, Suh K, Jung J: Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007;20:867-876.
16. Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ: Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 2003;9:95-103.
17. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS: Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-324.
18. Kim SJ, Cho HH, Kim YJ, Seo SY, Kim HN, Lee JB, Kim JH, Chung JS, Jung JS: Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochem Biophys Res Commun 2005;329:25-31.
19. Miranville A, Heeschen C, Sengenès C, Curat CA, Busse R, Bouloumié A: Improvement of postnatal neovascula-rization by human adipose tissue-derived stem cells. Circulation 2004;110:349-355.
20. Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Pénicaud L, Casteilla L: Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;109:656-663.
21. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109:1292-1298.
22. Moon MH, Kim SY, Kim YJ, Kim SJ, Lee JB, Bae YC, Jung JS: Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 2006;17:279-290.
23. Dufourcq P, Descamps B, Tojais NF, Leroux L, Oses P, Daret D, Moreau C, Lamazière JM, Couffinhal T, Duplàa C: Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells 2008;26:2991-3001.
24. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y: Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005;25:2542-2547.
25. Cai L, Johnstone BH, Cook TG, Liang Z, Traktuev D, Cornetta K, Ingram DA, Rosen ED, March KL: Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007;25:3234-3243.
26. Cho HH, Park HT, Kim YJ, Bae YC, Suh KT, Jung JS: Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem 2005;96:533-542.
27. Risau W: Mechanisms of angiogenesis. Nature 1997;386:671-674.
28. Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W: Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006;10:45-55.
29. Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL: The role of CXC chemokines as regulators of angiogenesis. Shock 1995;4:155-160.
30. Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M, Kitagawa Y, Murohara T. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2009; 29:61-66.
31. Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J: Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells: in vitro and in vivo comparison with natural forms of GRO, IP-10 and IL-8. J Immunol 1993;150:1000-1010.
32. Wuyts A, Struyf S, Gijsbers K, Schutyser E, Put W, Conings R, Opdenakker G, Billiau A, Van Damme J: The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. Lab Invest 2003;83:23-34.
33. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D: The functional role of the ELR motif in CXC chemokine-mediated angio-genesis. J Biol Chem 1995;270:27348-27357.
34. Van Coillie E, Van Aelst I, Wuyts A, Vercauteren R, Devos R, De Wolf-Peeters C, Van Damme J, Opdenakker G: Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am J Pathol 2001;159:1405-1414.
35. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ: Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1985;169:1485-1490.
36. Ikeda Y, Yonemitsu Y, Kataoka C, Kitamoto S, Yamaoka T, Nishida K, Takeshita A, Egashira K, Sueishi K: Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 2002;283:H2021-H2028.
37. Shireman PK: The Chemokine System in Arteriogenesis and Hind Limb Ischemia. J Vasc Surg 2007;45:A48-A56.
38. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W: Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997;80:829-837.
39. Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W: Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 2001;49:609-617.
40. Heil M, Ziegelhoeffer T, Wagner S, Fernández B, Helisch A, Martin S, Tribulova S, Kuziel WA, Bachmann G, Schaper W: Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004;94:671-677.
41. Cho HH, Bae YC, Jung JS: Role of tolllike receptors on human adipose-derived stromal cells. Stem Cells 2006;24:2744-2752.
42. Hong KH, Ryu J, Han KH: Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 2005;105:1405-1407.
43. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM: VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998;2:549-558.
44. Inoue S, Egashira K, Ni W, Kitamoto S, Usui M, Otani K, Ishibashi M, Hiasa K, Nishida K, Takeshita A: Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 2002;106:2700-2706